NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Illumina Inc (NASDAQ: ILMN)
ILMN Technical Analysis
5
As on 9th Jun 2023 ILMN SHARE Price closed @ 200.53 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 266.12 & Strong Sell for SHORT-TERM with Stoploss of 355.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ILMNSHARE Price
Open | 201.67 | Change | Price | % |
High | 202.40 | 1 Day | -2.19 | -1.08 |
Low | 199.60 | 1 Week | 3.88 | 1.97 |
Close | 200.53 | 1 Month | -3.86 | -1.89 |
Volume | 696300 | 1 Year | -178.93 | -47.15 |
52 Week High 423.80 | 52 Week Low 177.23 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ILMN Daily Charts |
ILMN Intraday Charts |
Whats New @ Bazaartrend |
ILMN Free Analysis |
|
ILMN Important Levels Intraday
RESISTANCE | 205.93 |
RESISTANCE | 204.20 |
RESISTANCE | 203.13 |
RESISTANCE | 202.06 |
SUPPORT | 199.00 |
SUPPORT | 197.93 |
SUPPORT | 196.86 |
SUPPORT | 195.13 |
ILMN Forecast April 2024
4th UP Forecast | 415.35 |
3rd UP Forecast | 346.46 |
2nd UP Forecast | 303.87 |
1st UP Forecast | 261.29 |
1st DOWN Forecast | 139.77 |
2nd DOWN Forecast | 97.19 |
3rd DOWN Forecast | 54.6 |
4th DOWN Forecast | -14.29 |
ILMN Weekly Forecast
4th UP Forecast | 248.49 |
3rd UP Forecast | 233.11 |
2nd UP Forecast | 223.60 |
1st UP Forecast | 214.10 |
1st DOWN Forecast | 186.96 |
2nd DOWN Forecast | 177.46 |
3rd DOWN Forecast | 167.95 |
4th DOWN Forecast | 152.57 |
ILMN Forecast2024
4th UP Forecast | 691.05 |
3rd UP Forecast | 533.74 |
2nd UP Forecast | 436.5 |
1st UP Forecast | 339.26 |
1st DOWN Forecast | 61.8 |
2nd DOWN Forecast | -35.44 |
3rd DOWN Forecast | -132.68 |
4th DOWN Forecast | -289.99 |
Illumina Inc ( NASDAQ USA Symbol : ILMN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ILMN Other Details
Segment | EQ | |
Market Capital | 64470175744.00 | |
Sector | Healthcare | |
Industry | Diagnostics & Research | |
Offical website | > echo $website ; ?> |
ILMN Address
ILMN Latest News
ILMN Business Profile
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California. Address: 5200 Illumina Way, San Diego, CA, United States, 92122
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service